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Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) strains have become common causes of skin and soft tissue
infections (SSTI) among previously healthy people, a role of methicillin-susceptible (MSSA) isolates before the mid-1990s.
We hypothesized that, as MRSA infections became more common among S. aureus infections in the community, perhaps
MSSA infections had become more important as a cause of healthcare-associated infection.
Methods: We compared patients, including children and adults, with MRSA and MSSA infections at the University of
Chicago Medical Center (UCMC) from all clinical units from July 1, 2004-June 30, 2005; we also compared the genotypes of
the MRSA and MSSA infecting bacterial strains.
Results: Compared with MRSA patients, MSSA patients were more likely on bivariate analysis to have bacteremia,
endocarditis, or sepsis (p=0.03), to be an adult (p=0.005), to be in the intensive care unit (21.9% vs. 15.6%) or another
inpatient unit (45.6% vs. 40.7%) at the time of culture. MRSA (346/545) and MSSA (76/114) patients did not differ
significantly in the proportion classified as HA-S. aureus by the CDC CA-MRSA definition (p=0.5). The genetic backgrounds
of MRSA and MSSA multilocus sequence type (ST) 1, ST5, ST8, ST30, and ST59 comprised in combination 94.5% of MRSA
isolates and 50.9% of MSSA isolates. By logistic regression, being cared for in the Emergency Department (OR 4.6, CI 1.5-
14.0, p=0.008) was associated with MRSA infection.
Conclusion: Patients with MSSA at UCMC have characteristics consistent with a health-care-associated infection more often
than do patients with MRSA; a possible role reversal has occurred for MSSA and MRSA strains. Clinical MSSA and MRSA
strains shared genotype backgrounds.
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Introduction
Staphylococcus aureus is among the most common pathogens
affecting human beings. It is a common cause of skin and soft
tissue infections (SSTIs), bloodstream infections, osteomyelitis,
septic arthritis, and device-related infections. Approximately 25-
40% of people are asymptomatically colonized with S. aureus [1].
The epidemiology of S. aureus changed at the end of the twentieth
century with the emergence of new strains, most often methicillin-
resistant (MRSA), that have circulated in the general population.
The new strains, known as community-associated (CA-) MRSA,
have been dominated by a single genetic background, USA300, a
pulsotype corresponding to ST8 by multilocus sequence typing (M.
David, unpublished data) [2]. They differ from the older health
care-associated (HA-) MRSA strains genotypically, in the popula-
tions they infect, and in the types of infections that they cause [3–5].
One distinctive feature of CA-MRSA strains is the almost universal
carriage of genes for the Panton-Valentine leukocidin (PVL), a toxin
rarely carried by S. aureus strains prior to the 1990s. CA-MRSA
strains have become the most common cause of SSTIs in U.S.
emergency rooms and in jails, typically among previously healthy
people [6,7]. Prior to the late 1990s, when MRSA isolates were
restricted to individuals in contact with the health care system,
methicillin-susceptible S. aureus (MSSA) strains were almost the
exclusive cause of both serious and uncomplicated S. aureus
infections among previously healthy people.
In the CA-MRSA era, the relationship between circulating
MRSA and MSSA strains in the U.S. has been examined for
asymptomatic colonization [8–15], SSTIs [9,16,17], and infections
among children [18]. However, the relationship among MSSA
and MRSA isolates causing infections of all kinds in children and
adults at a single center has not been recently examined.
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presenting for care from the community with MSSA infections,
we hypothesized that, as MRSA infections became more common
among S. aureus infections in the community, perhaps MSSA
infections had become less common. To explore this relationship
further, we studied a representative sample of MSSA and MRSA
infections at one center to compare the genotypic and phenotypic
characteristics of contemporary MSSA and MRSA isolates, risk
factors for MSSA and MRSA infection, and clinical syndromes
caused by MSSA and MRSA isolates.
Methods
Setting
The study was approved by the Institutional Review Board
(IRB) of the Biological Sciences Division of the University of
Chicago. Consent was provided by all subjects or by their parents
or guardians for their information to be stored for this study.
Informed consent was obtained by telephone in a procedure
approved by the IRB. The University of Chicago Medical Center
(UCMC) is an academic medical center located on the south side
of Chicago serving the surrounding inner-city population as well as
tertiary care referral patients.
MSSA isolate collection
The first 20 MSSA isolates identified by the Clinical
Microbiology Laboratory at UCMC each month were prospec-
tively collected from July 1, 2004 to June 30, 2005. S. aureus isolates
from 169 unique patients (referred to as patient-isolates when
analyzing patient-isolate dyads) were identified; isolates beyond the
first obtained from each patient were excluded. Of the 169
identified isolates, 6 could not be located and 5 were found on
further testing not to be S. aureus. Of the 158 eligible patients with
an available MSSA isolate, 60 (38%) were enrolled by telephone
and 87 (55%) were enrolled with a waiver of consent because they
could not be reached or were deceased in December 2008-June
2009; 11 (7.0%) declined enrollment.
MRSA isolate collection
Among 616 consecutive MRSA isolates obtained from UCMC
patients in July 1, 2004-June 30, 2005 as described [19],
19 71 were
excluded because the isolate represented asymptomatic carriage,
and 545 who had a clinical infection were included in the present
study. Clinical and demographic information about the patients
and genotypic and phenotypic information about the isolates was
tabulated as previously described [19].
Patient data
For the 147 enrolled MSSA patients, a physician (MZD)
abstracted the electronic and paper medical records at UCMC,
determining age, race/ethnicity as recorded in the chart, past
medical history, details of the clinical MSSA infection, and
putative risk factors for exposure to MRSA. Each patient
contacted for enrollment was also asked to complete a question-
naire concerning the above demographic, medical, and risk factor
topics on the telephone; 65% (39/60) of those contacted by
telephone completed this questionnaire. We applied the CDC case
definition, used to distinguish patients with CA- from HA-MRSA
infections, to assess the CA- or HA- status of MSSA isolates. The
CDC case definition classifies a patient as having a CA infection if
the isolate was obtained from an outpatient of from an inpatient
,48 hours after admission and lacks the following risk factors for
exposure to the health care system: hospitalization, hemodialysis,
or surgery in the previous year, presence of an indwelling catheter
at the time the culture is obtained [20]. Our definition differed
from the CDC criteria in that we considered surgery only in the
previous 6 months, rather than 12 months, to be a risk factor for
HA-MRSA infection.
Studies on MSSA isolates
Antimicrobial susceptibility testing to oxacillin, clindamycin,
erythromycin, rifampin, trimethoprim-sulfamethoxazole, vanco-
mycin, and gentamicin was performed with the Vitek 2 system
(bioMe ´rieux Vitek, Inc., Durham, NC). A D-zone test was
performed for inducible clindamycin resistance for isolates found
to be susceptible to clindamycin and resistant to erythromycin
according to CLSI guidelines [21]. D-zone test positive isolates
were considered to be resistant to clindamycin. Isolates reported to
have intermediate susceptibility to an antibiotic were considered to
be resistant. The MLST was determined for each MSSA isolate as
described [22]. Clonal complexes were assigned using the
eBURST algorithm as described. The presence of lukF-PV and
lukS-PV encoding the Panton-Valentine leukocidin (PVL) toxin
was performed by PCR as described [23].
Statistical analysis
Data were tabulated for each demographic, medical history,
and other patient characteristic factors. The CDC definition was
used to classify MSSA and MRSA isolates as CA- or HA-S. aureus
[20]. The risk factor data were compared for MSSA and MRSA
using x-square or Fisher Exact for dichotomous variables, or
Student’s t-test for continuous variables. Logistic regression models
were developed to test the independent association of all patient
and clinical variables with p , 0.05 on univariate analysis (Stata, v.
10, Statacorp, College Station, TX).
Results
Among the 147 MSSA isolates from enrolled patients, 33 were
excluded when they were determined to be colonizing and not
from a site of infection; 114 from clinical infections were analyzed
further. In the same period at UCMC, there were 545 MRSA
isolates from different patients with infections; 71 isolates
representing asymptomatic colonization were excluded [19].
Patients with an MSSA isolate were more likely to have private
insurance than MRSA patients (p=0.001). The racial/ethnic
make-up of the MSSA and MRSA patient groups differed (p ,
0.001); the MRSA group included a higher percent of African
Americans than the MSSA group (74.5% vs. 46.9%). Patients with
an MSSA isolate were more like to be an adult (75%) than were
MRSA patients (60.6%) (p=0.005). The most common MSSA
infectious syndromes were SSTI (47.4%), bacteremia, endocardi-
tis, or sepsis (19.3%), and osteomyelitis or septic arthritis (9.7%).
Compared with MRSA patients, MSSA patients were more likely
to have bacteremia, endocarditis, or sepsis (p=0.03). Patients with
a MRSA isolate were more likely to have an SSTI than MSSA
patients (p , 0.001) (Table 1).
MSSA isolates were more often obtained from inpatients more
than 48 hours after hospital admission than were MRSA (26.3%
vs. 19.5%), although the difference was not significant (p=0.1).
There was no significant difference in the percent of MRSA and
MSSA patients who had surgery in the previous 6 months, a
hospital or long-term care facility stay or hemodialysis in the
previous year, or an indwelling catheter at the time of culture.
There was no significant difference in the percent of MSSA and
MRSA patients, by self-report (p=0.3) or laboratory report at
UCMC (after 1993) (p=0.4), who had MRSA isolated in the past
(Table 2).
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significantly in the proportion that would be classified as HA-S.
aureus by the CDC CA-MRSA definition (p=0.5).
MSSA and MRSA patients did not differ significantly in the
likelihood that they had a comorbid condition, including an
immunocompromised state, diabetes mellitus, cystic fibrosis,
cancer, or HIV infection. Patients with MSSA were more likely
to be transplant recipients than MRSA patients (p=0.002). MRSA
patients were more likely than MSSA patients to have been in jail
(p=0.005). MRSA patients lived in larger households than MSSA
patients (p=0.047) (Table 3).
At the time of culture, MSSA patients were more likely than
MRSA patients to be in the intensive care unit (21.9% vs. 15.6%)
or another inpatient unit (45.6% vs. 40.7%) whereas MRSA
patients were more likely to be in the emergency department
(23.1% vs. 8.8%) (Figure 1).
The MSSA isolates were more polyclonal than were the MRSA
isolates. Among the MSSA isolates, there were 24 STs
(representing 12 clonal clusters [CC] and 2 STs that did not
belong to a defined CC). Among the MRSA isolates, there were 11
STs (in 6 CC). There was substantial overlap in the ST/CC
repertoire of the MRSA and MSSA isolates. ST1, ST5, ST8,
ST30, and ST59, all common genetic backgrounds of clinical
MRSA isolates in the U.S. and other parts of the world,
comprised, in aggregate, 94.5% of the MRSA isolates; among
the MSSA isolates, these STs comprised 50.9% of the aggregate
MSSA isolates (Figure 2, Table 4). Of MRSA isolates, 33% (180)
carried SCCmec type II and 67.7% (358) carried SCCmec type IV,
and 1.3% (7) did not SCCmec elements typable by the routine PCR
assays used.
PVL gene carriage (PVL+) was common among the MRSA
isolates; significantly fewer MSSA isolates were PVL+ (58.2% vs.
7.0%, p , 0.001). Among the 8 PVL+ MSSA isolates, 6 were ST8,
1 was ST1 and 1 was ST121. The proportion of PVL+ isolates did
not differ significantly among the ST8 MSSA (6/8, 75%) and ST8
MRSA (290/321, 90.3%) backgrounds (p=0.2). The syndromes
caused by the 6 ST8, PVL+ MSSA isolates were uncomplicated
SSTIs in 3 and an abscess associated with a transcutaneous gastric
tube, a surgical wound infection, and a central venous catheter-
associated bacteremia in 1 patient each. The ST121, PVL+ MSSA
isolate was obtained from a patient with septic arthritis and
pyomyositis; the ST1 PVL+ MSSA isolate came from a patient
with an uncomplicated SSTI. Among the 44 invasive MSSA
infections, just 2 (4.6%) were caused by PVL+ strains.
In Model 1, including a history of incarceration as a covariate,
African American race (OR 0.37, CI 0.15-0.91, p=0.03) and a
history of having ever been incarcerated (7.9 CI 1.7–36.9,
p=0.008) were independently associated with a MRSA infection.
Care in the Emergency Department (OR 3.4 compared with
patients from inpatient non-ICU units, CI 0.84–14.0, p=0.09) and
an increasing number of people in the household (OR 1.3, CI
0.98–1.7, p=0.07) trended toward significance among MRSA
patients. Only 184 patients were included in Model 1 because data
were available about history of incarceration from only 195 (48
MSSA and 147 MRSA) patients, and 11 of these lacked data on
other variables in the model (Table 5a). In Model 2, omitting the
history of incarceration (n=455), only care in the Emergency
Department (OR 4.6 compared with patients from inpatient non-
ICU units, CI 1.5–14.0, p=0.008) was significantly associated with
MRSA infection. Being a transplant patient trended toward a
significant association with MSSA infection (OR 0.40, CI 0.13–
1.1, p=0.08) (Table 5b).
Discussion
Our data yield three major conclusions. First, MSSA has, by
several criteria become a predominantly health-care-associated
pathogen among patients at UCMC. Moreover, MRSA patients
are no longer predominantly patients with recent exposure to the
health care setting. Thus, a possible role reversal has occurred for
MSSA and MRSA strains; before the mid-1990s, MRSA was almost
exclusively a health care-associated pathogen, and S. aureus infections
Table 1. Demographic and clinical characteristics of patients
with MSSA and MRSA infections.
MRSA,
No. of patients,
n=545 (%)
MSSA,
No. of patients,
n=114 (%) p-value
Clinical
syndrome
Bacteremia,
endocarditis,
or sepsis
63 (11.6) 22 (19.3) 0.03
Osteomyelitis
or septic arthritis
33 (6.1) 11 (9.7) 0.2
Pneumonia 46 (8.4) 8 (7.0) 0.6
Skin and soft
tissue infection
354 (65.0) 54 (47.4) ,0.001
Urinary tract
infection
22 (4.0) 2 (1.8) 0.4
Other* 27 (5.0) 17 (14.9) ,0.001
Type of
Infection
Invasive 175 (32.1) 44 (38.6) 0.2
Non-Invasive 370 (67.9) 70 (61.4) –
Age Group
Pediatric
(,18.0 years)
215 (39.5) 29 (25) 0.005
Adult 330 (60.6) 85 (75) –
Gender
Male 268 (49.2) 56 (49.1) 1.0
Female 277 (50.8) 58 (50.9) –
Race
African
American
406 (74.5) 53 (46.9) ,0.001
Caucasian 84 (15.4) 35 (31.0) –
Latino 11 (2.0) 8 (7.1) –
Native
American
3 (0.6) 1 (0.9) –
Unknown 41 (7.3) 17 (14.2) –
Type of
insurance
Public assistance 378 (69.4) 68 (59.7) 0.04
Private 132 (24.2) 45 (39.5) 0.001
Uninsured 19 (3.5) 1 (0.9) 0.2
Unknown 16 (2.9) 0 (0) –
*Includes abdominal abscess, toxic shock syndrome, cholecystitis, conjunctivitis,
peritonitis, empyema, neurosurgical device infection, uncertain site of culture,
and upper respiratory infection.
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA,
methicillin-susceptible Staphylococcus aureus.
doi:10.1371/journal.pone.0018217.t001
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MRSA, No. of patients,
n=545 (%)
MSSA, No. of patients,
n=114 (%) p-value
Inpatient culture obtained .48 hours after admission 106 (19.5) 30 (26.3) 0.1
Hospital stay, past year 225/458 (49.1) 57 (50.0) 0.9
Surgery, past 6 months 209/486 (43.0) 43 (37.7) 0.3
Hemodialysis, past year 35 (6.4) 9 (8.0) 0.6
Indwelling catheter 69 (12.7) 16 (14.0) 0.7
Previous MRSA isolation
Laboratory 58 (10.6) 15 (13.2) 0.4
report
Self-report only 9/281 (3.2) 1 (0.9) 0.3
Lived in long-term care facility, past year 16/290 (5.5) 2 (1.8) 0.1
*Absence of these risk factors comprise the CDC case definition for community-associated MRSA infections. Denominators for HA-MRSA risk factors exclude those
interviewed patients who answered that that they did not know information requested of them and those patients about whom risk factor information could not be
determined from chart review. For all 659 patients it was determined whether MRSA had been isolated from them at UCH since 1994, but for 295 patients, it could not
be determined if MRSA had been isolated from them at another health care facility. The information regarding a stay in a long-term care facility was determined only for
those patients lacking another health-care risk factor.
Abbreviations: HA-, health care associated; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus.
doi:10.1371/journal.pone.0018217.t002
Table 3. Additional Risk Factors and Putative Risk Factors for Exposure to MRSA.
MRSA, No. of patients,
n=545 (%)
MSSA, No. of patients,
n=114 (%) p-value
Antibiotic use in past 6 months 229 (42.1) 57 (50) 0.1
Immunocompromised* 80 (14.7) 22 (19) 0.2
Diabetes 103 (18.9) 24 (21) 0.6
Cancer 87 (16.0) 22 (19) 0.4
Transplant 12 (2.2) 9 (8.0) 0.002
Implant, hardware or other foreign body 88 (16.1) 20 (18) 0.7
HIV-infected 13 (2.4) 4 (3.5) 0.5
Attend daycare 31/215 (14.4) 3/29 (10) 0.8
Work in prison or jail 15 (2.8) 2 (1.8) 0.8
Been in prison or jail 41 (7.5) 1 (0.9) 0.005
Travel in previous 6 months 56 (10.3) 9 (7.9) 0.4
Intravenous drug use 29 (5.3) 2 (1.8) 0.1
Household healthcare contact{ 65/303 (21.5) 10/49 (20) 0.9
Household hospitalized contact{ 67/295 (22.7) 7/47 (15) 0.2
Number people in household, mean 6 s. d." 3.6662.16 3.1561.51 0.047
Number bedrooms in household mean 6 s. d.# 2.8861.28 2.8760.89 1.0
Number persons/bedroom in household, mean 6 s. d." 0.8960.03 1.0260.07 0.1
*Patients either had an inborn immunodeficiency or were infected with HIV at the time of culture or that they were taking immunosuppressive drugs at the time of
culture. Patients with diabetes mellitus, liver disease, cancer, or a rheumatologic disease were not considered to be immunocompromised in the absence of
immunosuppressive drug therapy.
{Denominators indicated are the number of patients interviewed who answered the relevant questions.
{For MRSA n=424; for MSSA, n=79.
#For MRSA n=277; for MSSA, n=45.
"For MRSA, n=276; for MSSA, n=45.
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus.
doi:10.1371/journal.pone.0018217.t003
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patients were more likely to have bacteremia, endocarditis, or sepsis,
to be transplant patients, to be adults, and to be in an intensive care
unit than MRSA patients. MSSA patients were also less likely than
MRSA patients to have an SSTI or to be treated in the emergency
department and released. MSSA and MRSA patients had a similar
likelihood of having an invasive infection. MRSA infections were not
more likely than MSSA infections to occur among patients with a
number of chronic diseases.
The second conclusion is that there was considerable overlap in
the MLST genotypes of MRSA and MSSA strains. Although the
MSSA strains we studied were more polyclonal than the MRSA
strains, as others have noted [24], we found that both the MRSA
and MSSA isolates from patients seeking care for infections mostly
fell into 5 STs: ST1, ST5, ST8, ST30, and ST59, all common
MRSA genetic backgrounds in various regions of the world. Thus,
despite the emergence of novel CA-MRSA strains during the
previous decade in Chicago, the genotypic backgrounds among
MSSA strains causing infections at our center maintained
substantial genotypic overlap with MRSA strains.
Third, we have demonstrated that MSSA strains causing clinical
infections rarely carry genes for the PVL toxin (7.0%), in contrast
to MRSA strains (58.2%) even in the era of epidemic CA-MRSA.
The low prevalence of PVL gene carriage in MSSA strains is
consistent with reports from European centers prior to the
emergence of CA-MRSA [24]. Further research is needed to
determine why PVL toxin genes are almost universally carried by
CA-MRSA strains but remain rare among MSSA and HA-MRSA
Figure 1. Percent of patients with MRSA and MSSA infections who had cultures obtained in various sites of care; emergency
department patients include only those cultured and not admitted to the hospital.
doi:10.1371/journal.pone.0018217.g001
Figure 2. Percent of MSSA and MRSA isolates from UCMC, July 1, 2004-June 30, 2005, belonging to ST1, ST5, ST8, ST30, ST59, and
other genetic backgrounds.
doi:10.1371/journal.pone.0018217.g002
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MRSA MSSA
Number (n=545) Percent Number (n=114) Percent
Clonal complex type/MLST
Clonal complex 1*
1 21 3.9 5 4.4
188 0 0 1 0.9
573 0 0 1 0.9
Clonal complex 5
5 170 31.3 9 7.9
5slv{ 1 0.2 1 0.9
105 3 0.6 0 0
231 14 2.6 0 0
Clonal complex 8
8 321 58.9 14 12.3
8slv{ 20 . 30 0
72 1 0.2 5 4.4
1181 0 0 1 0.9
Clonal complex 9
9 0 010 . 9
109 0 0 4 3.5
Clonal complex 12
1 2 0 010 . 9
12slv{ 0 010 . 9
Clonal complex 15
1 5 0 087 . 0
582 0 0 1 0.9
Clonal complex 20
2 0 0 032 . 6
Clonal complex 22
22 6 1.1 0 0
Clonal complex 30
30 0 0 25 21.9
30slv{ 0 010 . 9
36 3 0.6 0 0
3 9 0 010 . 9
Clonal complex 59
59 2 0.4 5 4.4
Clonal complex 97
9 7 0 021 . 8
Clonal complex 121
121 0 0 1 0.9
Clonal complex 182
182slv{ 0 010 . 9
Singletons
580 0 0 1 0.9
1159 0 0 1 0.9
*CC1 was subsumed by the CC15 by the MLST administrators.
{slv, single locus variant.
Abbreviations: MLST, multilocus sequence typing; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus.
doi:10.1371/journal.pone.0018217.t004
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or they represent virulence determinants in these strains that
became widespread in the late 1990s.
Most MSSA strains that were PVL+ were ST8, the same ST of
strains with the USA300 pulsotype, and most ST8 strains were
obtained from uncomplicated SSTIs, the most common type of
infection caused by CA-MRSA in many studies in the U.S. These
data indicate an association between ST8 S. aureus strains, regardless
of the methicillin resistance phenotype, and presence of an SSTI.
Others have also found that MSSA strains commonly cause
invasive infections.
4, 18 The importance of ST8 (consistent with
USA300) among MSSA invasive disease isolates, however, is
unclear. We found that ST8 MSSA isolates were infrequently
responsible for invasive disease although others have established
an important role for ST8 isolates among invasive infections in
children [17,25]. We also found few invasive infections caused by
PVL+ MSSA strains. The results of these studies may differ
because we also studied adults or because of temporal or
geographic variation in the MRSA epidemic.
Our study suggests that patients living in poverty and
underserved populations are at higher risk for a MRSA infection,
but not an MSSA infection. Private insurance was more common
among MSSA than MRSA patients, and MRSA patients were
more commonly treated in the emergency department. This is
consistent with our finding that MSSA infections reflect epidemi-
ologic characteristics of nosocomial or health-care associated
infections. Our patients with MSSA isolates were not as likely as
patients with CA-MRSA infections to be previously healthy and
presenting for care from the community.
Other studies have compared MRSA and MSSA patients, but
they have been limited by a lack of genotyping data, or limited to
isolates obtained from skin infections and/or CA-S. aureus
infections (defined by various criteria) [4,16–18,26,27]. McCarthy
et al. examined MRSA and MSSA infections among military
veterans in Atlanta in 2007–2008 and found that MRSA patients
were more likely to have had a previous MRSA infection and to
have had a stay in a long-term care facility in the previous year,
but less likely to have had a biopsy in the previous year [27]. We
did not find the same distinctions, perhaps because of differences
in the populations studied.
There are limitations to our study. We examined S. aureus
infections at one medical center in one city. The MSSA patients
studied were not a complete cohort, but the 114 patients and
isolates that we examined were a carefully designed sample that is
likely representative of all MSSA infections at our institution.
In conclusion, MSSA has reversed roles with MRSA. In the era
of epidemic CA-MRSA infections, MSSA isolates have assumed
the role of a nosocomial pathogen among the debilitated, while
CA-MRSA strains continue to predominate among patients in our
inner-city community.
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